Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis 81 countries and subnational settings demonstrated that >40% of RMP-resistant isolates from new TB cases did not display resistance to isoniazid (INH) in settings with relatively low MDR-TB prevalence (one third of all countries and subnational settings). Results indicated the need for INH susceptibility testing in addition to RMP susceptibility testing.'>
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis
  • Published Date:

    2012 Feb

  • Source:
    Int J Tuberc Lung Dis. 16(2):203-205
  • Language:
    English
Filetype[PDF-96.51 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 27.00 KB]
    Personal Author:
    Brust, James C.M.; Shah, N. Sarita; Gandhi, Neel R.;
    Published Date:
    Dec 29 2016
    Source:
    N Engl J Med. 375(26):2610.
    File Type:
    Filetype[PDF - 27.00 KB]
  2. Filetype[PDF - 239.87 KB]
    Personal Author:
    Click, E. S.; Chirenda, J.; Kibias, S.; Menzies, H. J.; Oeltmann, J. E.; Sentle, C.; Muribe, T.; Lere, T. D.; Makombe, R.; Bamrah, S.; Moore, B. K.; Cain, K. P.;
    Published Date:
    Nov 2014
    Source:
    Int J Tuberc Lung Dis. 18(11):1319-1322
    Description:
    We linked results from the Fourth Botswana National Drug Resistance Survey (DRS), 2007-2008, to patient records from the national Electronic Tuberculosis Registry to determine treatment outcomes. Of 915 new patients, 651 (71%) had treatment data avai...
    File Type:
    Filetype[PDF - 239.87 KB]
  3. Filetype[PDF - 223.08 KB]
    Personal Author:
    Balcells, Maria Elvira; Thomas, Sara L.; Godfrey-Faussett, Peter; Grant, Alison D.;
    Published Date:
    May 2006
    Source:
    Emerg Infect Dis. 12(5):744-751.
    Description:
    In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for development of isoniazid-resistant tuberculosis may hinder its widespread implementation. We conducted a syst...
    File Type:
    Filetype[PDF - 223.08 KB]
  4. Filetype[PDF - 116.57 KB]
    Personal Author:
    Gandhi, Neel R.; Brust, James C.M.; Shah, N. Sarita;
    Published Date:
    October 04 2018
    Source:
    Eur Respir J. 52(4)
    File Type:
    Filetype[PDF - 116.57 KB]
  5. Filetype[PDF - 120.90 KB]
    Personal Author:
    Kurbatova, Ekaterina V.; Cavanaugh, J. Sean; Shah, N. Sarita; Wright, Abigail; Kim, HeeJin; Metchock, Beverly; Van Deun, Armand; Barrera, Lucia; Boulahbal, Fadila; Richter, Elvira; Martín-Casabona, Nuria; Arias, Fabiola; Zemanova, Ilona; Drobniewski, Francis; Silva, Anabela Santos; Coulter, Christopher; Lumb, Richard; Cegielski, J. Peter;
    Published Date:
    2012
    Source:
    Int J Tuberc Lung Dis. 16(3):355-357
    Description:
    Based on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). R...
    File Type:
    Filetype[PDF - 120.90 KB]